...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >High affinity binding of factor XIIa to an electronegative surface controls the rates of factor XII and prekallikrein activation in vitro.
【24h】

High affinity binding of factor XIIa to an electronegative surface controls the rates of factor XII and prekallikrein activation in vitro.

机译:因子XIIa与负电性表面的高亲和力结合可控制因子XII和前激肽释放酶在体外的活化速率。

获取原文
获取原文并翻译 | 示例
           

摘要

The incubation of normal human plasma in the presence of sulphatide vesicles results in the generation of amidolytic activity due to factor XIIa (FXIIa) and to kallikrein (KRN). The progress of the generation of the enzymes distinguished a high initial rate of enzyme generation, a decline of this rate to maximum amidolytic activity ([FXIIa]m and [KRN]m) and a negative pseudo-first-order rate attributed to enzyme inactivation by plasma C1-inhibitor (C1INH). [FXIIa]m and [KRN]m were determined after the treatment of various dilutions of plasma in the presence of 4, 15, or 40 microM sulphatide vesicles. At all levels of sulphatides, [FXIIa]m and [KRN]m initially increased with the concentration of plasma, to reach a plateau at higher concentration of plasma. The plateau activities of the generated enzymes and the optimal concentration of plasma both increased with the level of sulphatide vesicles. The pseudo-first-order inactivation rate for KRN increased progressively with the concentration of plasma but the respective rate for FXIIa was independent of the plasma concentration. The data suggest that contiguous binding of plasma FXIIa, factor XII (FXII), and the complexes of high molecular weight kininogen (HK) with prekallikrein (HK-PKRN) and factor XI (HK-FXI) to an electronegative surface induces a rapid generation of FXIIa and KRN. The concentration of the electronegative surface controls the levels of generated FXIIa and KRN and their release to the bulk phase. The released FXIIa and KRN are both inactivated by C1INH.
机译:在存在硫化物囊泡的情况下,正常人血浆的孵育会导致由于因子XIIa(FXIIa)和激肽释放酶(KRN)而产生酰胺分解活性。酶产生的进展区分了高的初始酶产生速率,该速率降低至最大酰胺分解活性([FXIIa] m和[KRN] m)以及归因于酶失活的负一级伪速率。由血浆C1抑制剂(C1INH)产生。在存在4、15或40 microM硫酸盐囊泡的情况下,对血浆的各种稀释液进行处理后,测定[FXIIa] m和[KRN] m。在所有硫化物水平下,[FXIIa] m和[KRN] m最初随血浆浓度增加,在血浆浓度较高时达到平稳状态。所产生的酶的平台活性和血浆的最佳浓度均随硫苷脂囊泡水平的增加而增加。 KRN的拟一阶失活率随着血浆浓度的增加而逐渐增加,但是FXIIa的各自速率与血浆浓度无关。数据表明血浆FXIIa,XII因子(FXII)以及高分子量激肽原(HK)与激肽释放酶(HK-PKRN)和XI因子(HK-FXI)的复合物与负电性表面的结合会诱导快速生成FXIIa和KRN。负电性表面的浓度控制着生成的FXIIa和KRN的水平以及它们释放到本体相中的水平。释放的FXIIa和KRN均被C1INH灭活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号